転写因子が子宮内膜症におけるアポトーシスをどのように調節するか (レビュー)
Zhuqing Ouyang1, Juexiao Deng1, Lanyue Zhang1
1Department of Gynaecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Molecular medicine reports
|August 24, 2025
まとめ
転写因子は細胞死における重要なプロセスであるアポトーシスを調節し,これは子宮内膜症では制御不能である. これらのメカニズムの理解は この一般的な婦人科疾患の 新しい治療法につながります
科学分野:
- 婦人科
- 細胞生物学
- 分子生物学
背景:
- 子宮内膜症 (EM) は,生殖年齢の女性の10%に影響を与える一般的な婦人科疾患です.
- 子宮の外側の子宮内膜組織が 骨盤の痛みや不妊症を引き起こします
- アポトーシスの調節不全,炎症,酸化ストレスがEM病原性に関与している.
研究 の 目的:
- 子宮内膜症におけるアポトーシスの制御における転写因子の役割を検討する.
- EM治療の潜在的治療目標とバイオマーカーを特定する.
主な方法:
- このレビューは,EMにおける転写因子媒介のアポトーシスに関する既存の研究をまとめています.
- 転写因子を病気におけるアポプトシス不調と結びつけるメカニズムに焦点を当てています.
主要な成果:
- アポプトーシスの抑制は子宮外子宮細胞の生存とEMの発達に不可欠です.
- 転写因子はアポトーシスの重要な調節因子であり,EMの病原性に影響を与えます.
- 特定の転写因子は,バイオマーカーおよび治療標的として潜在的な可能性を秘めています.
結論:
- 転写因子調節されたアポトーシス経路をターゲットにすることは,新しい子宮内膜症治療のための有望な戦略です.
- これらのメカニズムのさらなる研究により,EMの診断と治療方法が改善できます.
関連する概念動画
Apoptosis
11.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K


